Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Squamous Cell | 4 | 2022 | 29 | 0.340 |
Why?
|
| Mouth Neoplasms | 1 | 2010 | 1 | 0.310 |
Why?
|
| Tongue Neoplasms | 2 | 2018 | 7 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 3 | 2012 | 9 | 0.210 |
Why?
|
| Cell-Derived Microparticles | 1 | 2022 | 4 | 0.180 |
Why?
|
| Laryngeal Neoplasms | 1 | 2021 | 4 | 0.170 |
Why?
|
| Chondrosarcoma | 1 | 2021 | 9 | 0.170 |
Why?
|
| Disease-Free Survival | 5 | 2018 | 30 | 0.170 |
Why?
|
| Humans | 11 | 2022 | 5837 | 0.160 |
Why?
|
| Male | 8 | 2021 | 3399 | 0.160 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 6 | 0.160 |
Why?
|
| Urban Health Services | 1 | 2020 | 6 | 0.160 |
Why?
|
| Otolaryngology | 1 | 2020 | 10 | 0.160 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2000 | 1 | 0.160 |
Why?
|
| Deglutition Disorders | 1 | 2000 | 6 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 19 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 32 | 0.160 |
Why?
|
| Prostheses and Implants | 2 | 1997 | 71 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 23 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 24 | 0.150 |
Why?
|
| Telemedicine | 1 | 2020 | 30 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2021 | 51 | 0.150 |
Why?
|
| Female | 8 | 2021 | 3346 | 0.150 |
Why?
|
| Neoplasm Staging | 5 | 2021 | 74 | 0.150 |
Why?
|
| Middle Aged | 5 | 2021 | 1775 | 0.130 |
Why?
|
| Radiometry | 1 | 1997 | 2 | 0.130 |
Why?
|
| Biocompatible Materials | 1 | 1997 | 23 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2021 | 584 | 0.110 |
Why?
|
| Cicatrix | 1 | 1994 | 1 | 0.110 |
Why?
|
| Facial Neoplasms | 1 | 1994 | 1 | 0.110 |
Why?
|
| Carcinoma | 1 | 1994 | 11 | 0.110 |
Why?
|
| Burns | 1 | 1994 | 10 | 0.110 |
Why?
|
| Aged | 6 | 2021 | 1860 | 0.100 |
Why?
|
| Elementary Particles | 1 | 2013 | 2 | 0.100 |
Why?
|
| Nuclear Physics | 1 | 2013 | 2 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2013 | 27 | 0.100 |
Why?
|
| Quinazolines | 1 | 2012 | 2 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 9 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 16 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 48 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2008 | 35 | 0.080 |
Why?
|
| Osteoradionecrosis | 1 | 2010 | 1 | 0.080 |
Why?
|
| Deglutition | 1 | 2010 | 2 | 0.080 |
Why?
|
| Adolescent | 3 | 2018 | 488 | 0.080 |
Why?
|
| Survival Rate | 2 | 2021 | 60 | 0.080 |
Why?
|
| Adult | 4 | 2018 | 1670 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 333 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2021 | 37 | 0.060 |
Why?
|
| Neck Dissection | 1 | 2004 | 1 | 0.050 |
Why?
|
| Prognosis | 2 | 2004 | 138 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 6 | 0.050 |
Why?
|
| Apoptosis | 1 | 2022 | 65 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 94 | 0.040 |
Why?
|
| Laryngectomy | 1 | 2021 | 4 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2021 | 12 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 15 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 67 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 54 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 601 | 0.040 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 8 | 0.040 |
Why?
|
| Barium Sulfate | 1 | 2000 | 1 | 0.040 |
Why?
|
| Video Recording | 1 | 2000 | 5 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2000 | 7 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 18 | 0.040 |
Why?
|
| Contrast Media | 1 | 2000 | 16 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 63 | 0.040 |
Why?
|
| United States | 1 | 2021 | 502 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 17 | 0.040 |
Why?
|
| Age Factors | 1 | 2018 | 181 | 0.030 |
Why?
|
| Polyesters | 1 | 1997 | 1 | 0.030 |
Why?
|
| Stainless Steel | 1 | 1997 | 3 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 1997 | 10 | 0.030 |
Why?
|
| Durapatite | 1 | 1997 | 7 | 0.030 |
Why?
|
| Alloys | 1 | 1997 | 25 | 0.030 |
Why?
|
| Titanium | 1 | 1997 | 64 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 1997 | 1 | 0.030 |
Why?
|
| Vocal Cord Paralysis | 1 | 1997 | 1 | 0.030 |
Why?
|
| Granuloma, Foreign-Body | 1 | 1997 | 1 | 0.030 |
Why?
|
| Thyroid Diseases | 1 | 1997 | 3 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 1997 | 7 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 421 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 1034 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 14 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 4 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2008 | 3 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2008 | 6 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2008 | 4 | 0.020 |
Why?
|
| Carboplatin | 1 | 2008 | 5 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 16 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 406 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2004 | 7 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2004 | 5 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 4 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 15 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 22 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 15 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2004 | 10 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2004 | 10 | 0.010 |
Why?
|